- Home
- MPLX vs IDXX Comparison
MPLX vs IDXX Comparison
Compare MPLX & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPLX
- IDXX
- Stock Information
- Founded
- MPLX 2012
- IDXX 1983
- Country
- MPLX United States
- IDXX United States
- Employees
- MPLX N/A
- IDXX N/A
- Industry
- MPLX Oil & Gas Production
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MPLX Energy
- IDXX Health Care
- Exchange
- MPLX Nasdaq
- IDXX Nasdaq
- Market Cap
- MPLX 51.7B
- IDXX 51.3B
- IPO Year
- MPLX 2012
- IDXX 1991
- Fundamental
- Price
- MPLX $51.27
- IDXX $643.99
- Analyst Decision
- MPLX Buy
- IDXX Buy
- Analyst Count
- MPLX 9
- IDXX 7
- Target Price
- MPLX $55.89
- IDXX $610.71
- AVG Volume (30 Days)
- MPLX 1.2M
- IDXX 376.7K
- Earning Date
- MPLX 11-04-2025
- IDXX 10-30-2025
- Dividend Yield
- MPLX 7.46%
- IDXX N/A
- EPS Growth
- MPLX 2.17
- IDXX 19.17
- EPS
- MPLX 4.21
- IDXX 12.01
- Revenue
- MPLX $11,486,000,000.00
- IDXX $4,037,715,000.00
- Revenue This Year
- MPLX $14.64
- IDXX $10.76
- Revenue Next Year
- MPLX $4.33
- IDXX $8.15
- P/E Ratio
- MPLX $12.18
- IDXX $53.96
- Revenue Growth
- MPLX 4.67
- IDXX 6.68
- 52 Week Low
- MPLX $43.53
- IDXX $356.14
- 52 Week High
- MPLX $54.87
- IDXX $688.12
- Technical
- Relative Strength Index (RSI)
- MPLX 56.83
- IDXX 55.39
- Support Level
- MPLX $49.81
- IDXX $625.55
- Resistance Level
- MPLX $51.49
- IDXX $655.77
- Average True Range (ATR)
- MPLX 0.69
- IDXX 12.62
- MACD
- MPLX 0.09
- IDXX -3.29
- Stochastic Oscillator
- MPLX 81.56
- IDXX 61.02
About MPLX MPLX LP
MPLX is a partnership that owns pipelines and gathering and processing assets with extensive holdings in the Appalachian and Permian regions. The asset base is made up of crude oil and refined products assets dropped down from Marathon Petroleum, its sponsor, and natural gas and natural gas liquids gathering and processing assets that were purchased or built.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.